Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium

Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells

(2012) L. A. Birder et al.   Acta Physiologica

Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder

(2012) Youko Ikeda et al.   EUROPEAN UROLOGY

Botulinum toxin type A for the treatment of lower urinary tract disorders

(2012) Teruhiko Yokoyama et al.   INTERNATIONAL JOURNAL OF UROLOGY

Differential Effects of Botulinum Neurotoxin A on Bladder Contractile Responses to Activation of Efferent Nerves, Smooth Muscles and Afferent Nerves in Rats

(2012) Ryosuke Takahashi et al.   JOURNAL OF UROLOGY

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Botulinum toxin’s axonal transport from periphery to the spinal cord

(2012) Ivica Matak et al.   NEUROCHEMISTRY INTERNATIONAL

Botulinum Neurotoxin A Impairs Neurotransmission Following Retrograde Transynaptic Transport

(2012) Laura Restani et al.   TRAFFIC

In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization

(2011) Anthony P. Ford   Purinergic Signalling

Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery

(2011) Erkan Kiris et al.   Stem Cell Research

Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway

(2010) Puneet Khandelwal et al.   EMBO JOURNAL

Trigonal Injection of Botulinum Toxin A in Patients with Refractory Bladder Pain Syndrome/Interstitial Cystitis

(2010) Rui Pinto et al.   EUROPEAN UROLOGY

Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration

(2010) Soumendra N. Datta et al.   JOURNAL OF UROLOGY

Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity

(2010) Christopher Dowson et al.   Nature Reviews Urology

The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord

(2010) J. Mika et al.   NEUROSCIENCE

In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results

(2009) Thomas M. Kessler et al.   EUROPEAN UROLOGY

Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder

(2009) Ana Coelho et al.   EUROPEAN UROLOGY

Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Liposomes

(2009) Yao-Chi Chuang et al.   JOURNAL OF UROLOGY

Botulinum A Toxin/Dimethyl Sulfoxide Bladder Instillations for Women With Refractory Idiopathic Detrusor Overactivity: A Phase 1/2 Study

(2009) Steven P. Petrou et al.   MAYO CLINIC PROCEEDINGS

Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation

(2008) Alvaro Lucioni et al.   BJU INTERNATIONAL

Intravesical Botulinum Toxin A Administration Inhibits COX-2 and EP4 Expression and Suppresses Bladder Hyperactivity in Cyclophosphamide-Induced Cystitis in Rats

(2008) Yao-Chi Chuang et al.   EUROPEAN UROLOGY

Distinct Apical and Basolateral Membrane Requirements for Stretch-induced Membrane Traffic at the Apical Surface of Bladder Umbrella Cells

(2008) Weiqun Yu et al.   MOLECULAR BIOLOGY OF THE CELL

Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury

(2007) Christopher P. Smith et al.   NEUROCHEMISTRY INTERNATIONAL